Sensirion founders win Entrepreneur of the Year Award
Recognised for their innovation, flexibility and willingness to take risks
The Award is given to successful entrepreneurs who combine personal commitment and risk-taking to help strengthen the competitiveness of the Swiss economy.
Sensirion was set up in 1998 as a spin-off from ETH Zurich and has since established itself as a leading hi-tech company developing humidity- and temperature sensors, mass flow controllers, flow sensors for gases and fluids, as well as differential pressure sensors.
Headquartered near Zurich, it now employs more than 200 people and also has offices in the US, Japan, South Korea and China.
Describing Sensirion as ‘solid, consistent, innovative, cosmopolitan and still modest’, the judges also said the firm’s distinctive corporate culture had contributed to its success.
‘Winning the Entrepreneur of the Year 2010 Award is for us, both confirmation and motivation to serve our customers time and again with innovative and requirement-oriented sensor solutions,’ said Lechner.
Bruno Chiomento, chief executive of Ernst & Young Switzerland, said despite the difficult economic environment, entrepreneurship in Switzerland is in full bloom. He said the winners had been successful because of their innovation, flexibility and willingness to take risks.
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence